Paediatric Inflammatory Bowel Disease: : A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents Background and Aims: Despite recent approvals for new drugs to treat adults with Crohn’s disease or ulcerative colitis, there are only two ap[1]proved advanced treatment options [infliximab and adalimumab] for children with inflammatory bowel disease [IBD]. There are…
Risk-proportionate approach to Paediatric Clinical Trials: The legal requirements, challenges, and the way forward under the European Union Clinical Trials Regulation has been published by Clinical Trials
Registration for 4th Joint Nordic Conference on Paediatric Medicines is now open!
The Early Bird Fees rates application for EFGCP Better Medicines for Children 2022 are ending today – 18/07/2022.
Today’s spotlight is on Kristina an Haack from pharmaceutical company Sanofi, who helps developing training programmes within c4c.
Mental health disorders are prevalent in paediatric ages.
HELPnet (Hellenic Paediatric Network) is the Greek National network of paediatric clinical research sites.
In collaboration with c4c, CDISC is developing a Paediatrics User Guide which is now available for public review.
DanPedMed is the Danish National Hub in the connect4children (c4c) project and is represented as a third party to the c4c beneficiary HUS-Norway. DanPedMed is working towards becoming an independent Danish National Hub, after the initial c4c IMI funding period concludes in 2024. DanPedMed was established in 2016 through a collaboration between Danish Pediatric Society…
On 27th May 2022, the STAND4Kids National Hub is organizing an online event “Networking to improve pediatric research”.